Suchergebnisse - "2019-nCoV"

PubPharm (124)

1

Impact of shift work and other work-related factors on anti-SARS-CoV-2 spike-protein serum concentrations in healthcare workers after primary mRNA vaccination - a retrospective cohort study

enthalten in: Swiss medical weekly | 2024

von Menghini, G. | Thurnheer, R. | Kahlert, C. | +5

2

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates

enthalten in: Science immunology | 2023

von Routhu, N. | Stampfer, S. | Lai, L. | +25

3

Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2

enthalten in: Science translational medicine | 2023

von Stewart-Jones, G. | Elbashir, S. | Wu, K. | +22

UpdateOf: bioRxiv. 2022 Oct 07;:. - PMID 36238717

4

SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines

enthalten in: Human vaccines & immunotherapeutics | 2023

von Hickey, T. | Kemp, T. | Bullock, J. | +6

5

Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice

enthalten in: Vaccine | 2023

von Lee, K. | Rader, N. | Miller-Stump, O. | +7

6

Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern

enthalten in: Journal of medical virology | 2023

von García-Pérez, J. | Bermejo, M. | Ramírez-García, A. | +14

7

NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022

von Hielscher, F. | Schmidt, T. | Klemis, V. | +9

8

Neutralizing antibodies to SARS-CoV-2 variants of concern including Delta and Omicron in subjects receiving mRNA-1273, BNT162b2, and Ad26.COV2.S vaccines

enthalten in: Journal of medical virology | 2022

von Zhang, G. | Meng, W. | Chen, L. | +9

9

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

enthalten in: The Journal of infectious diseases | 2022

von El Sahly, H. | Baden, L. | Essink, B. | +21

10

Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination

enthalten in: The New England journal of medicine | 2022

von Shen, X. | Chalkias, S. | Feng, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]